Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis)
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis) |
Type de publication | Journal Article |
Year of Publication | 2021 |
Auteurs | Bertrand P-jean, Jamilloux Y, Kodjikian L, Errera M-H, Perard L, Pugnet G, Tieulie N, Andre M, Bielefeld P, Bron AM, Decullier E, Bin S, Seve P |
Journal | BRITISH JOURNAL OF OPHTHALMOLOGY |
Volume | 105 |
Pagination | 935-940 |
Date Published | JUL |
Type of Article | Article |
ISSN | 0007-1161 |
Mots-clés | Immunology, inflammation, Vision |
Résumé | Aims To assess vision-related (VR-QOL) and health-related quality of life (HR-QOL) in a large series of patients with de novo uveitis at baseline and 6-month follow-up. Methods Non-inferiority, prospective, multicentre, cluster randomised controlled trial registered under the Unique Identifier: NCT01162070. VR-QOL and HR-QOL were assessed by the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) and the Medical Outcomes Study 36-item Short Form Survey (SF-36). Results At inclusion, 466 patients completed the VFQ-25. The mean composite score was 80.0 (+/- 16.7). In multivariate analysis, higher age, female sex and insidious onset were significantly associated with lower QOL. At 6 months, 138 patients completed the VFQ-25, with a significantly higher mean composite score of 82.6 (+/- 16.7). SF-36 mental component was 42.9 (+/- 11.3) and physical component was 47.2 (+/- 8.5) at inclusion (n=425). HR-QOL improvement at 6 months was not clinically significant. Conclusion QOL seems relatively well preserved in this cohort; only VR-QOL improved significantly at 6 months, especially in patients with low initial visual acuity. |
DOI | 10.1136/bjophthalmol-2020-315862 |